Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
752 |
|
| Actual shortage: | 21 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 642 (85%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
98 (10%) |
|
Overdue reports |
2 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-17 | 2019-09-26 | 94099 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-02-05 | 2021-03-17 | 133432 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-05-19 | 2019-03-09 | 10718 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2019-03-13 | 2024-12-10 | 78454 |
| MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2022-06-09 | 2022-07-12 | 162343 |
| MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
| MYL-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-01-21 | 2025-10-29 | 248183 |
| MYL-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-10-29 | 2025-12-01 | 270539 |
| MYL-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23160 |
| MYL-PROPAFENONE | 300MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23163 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-PRAVASTATIN | 40MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16032 |
| MYLAN-PRAVASTATIN | 20MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16148 |
| MYLAN-PREGABALIN | 25MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51561 |
| MYLAN-PREGABALIN | 50MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51567 |
| MYLAN-PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51573 |
| MYLAN-PREGABALIN | 150MG | CAPSULE | Discontinued | 2018-06-05 | 2018-08-01 | 51582 |
| MYLAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51588 |
| MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
| MYLAN-QUETIAPINE | 100MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6781 |
| MYLAN-QUETIAPINE | 200MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6784 |
| MYLAN-QUETIAPINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6788 |
| MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16039 |
| MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16042 |
| MYLAN-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6792 |
| MYLAN-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6797 |
| MYLAN-RAMIPRIL | 5.0MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6801 |
| MYLAN-RAMIPRIL | 10MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6805 |
| MYLAN-RANITIDINE | 150MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6808 |
| MYLAN-RANITIDINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6811 |
| MYLAN-RISEDRONATE | 150MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16049 |